Estimates Revisions Capricor Therapeutics, Inc.
Stocks
CAPR
US14070B3096
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:01 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.060 USD | -3.82% |
|
+8.24% | -68.61% |
| 15/09 | Capricor Therapeutics Shares Rise After Upgrade From B. Riley | MT |
| 14/09 | B. Riley Upgrades Capricor Therapeutics to Buy From Neutral, Raises Price Target to $21 From $5 | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CAPR Stock
- Consensus Capricor Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
